Nothing Special   »   [go: up one dir, main page]

Wanjalla et al., 2023 - Google Patents

CD4+ T cells expressing CX3CR1, GPR56, with variable CD57 are associated with cardiometabolic diseases in persons with HIV

Wanjalla et al., 2023

View HTML
Document ID
9889475743006638815
Author
Wanjalla C
Gabriel C
Fuseini H
Bailin S
Mashayekhi M
Simmons J
Warren C
Glass D
Oakes J
Gangula R
Wilfong E
Priest S
Temu T
Newell E
Pakala S
Kalams S
Gianella S
Smith D
Harrison D
Mallal S
Koethe J
Publication year
Publication venue
Frontiers in immunology

External Links

Snippet

Persons with HIV (PWH) on long-term antiretroviral therapy (ART) have a higher incidence and prevalence of cardiometabolic diseases attributed, in part, to persistent inflammation despite viral suppression. In addition to traditional risk factors, immune responses to co …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Similar Documents

Publication Publication Date Title
Sattler et al. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients
Kalfaoglu et al. T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis
Latorre et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons
Woodruff et al. Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation
Pitard et al. Long-term expansion of effector/memory Vδ2− γδ T cells is a specific blood signature of CMV infection
Grivel et al. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo
Wikby et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study
Trzonkowski et al. Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients
Hou et al. Establishment of the reference intervals of lymphocyte function in healthy adults based on IFN-γ secretion assay upon phorbol-12-myristate-13-acetate/ionomycin stimulation
Ma et al. NKG2C+ NKG2A− natural killer cells are associated with a lower viral set point and may predict disease progression in individuals with primary HIV infection
Aiello et al. PTSD is associated with an increase in aged T cell phenotypes in adults living in Detroit
Toga et al. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis
Kared et al. Adaptive NKG2C+ CD57+ natural killer cell and Tim-3 expression during viral infections
Palendira et al. Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow
Hosie et al. Cytomegalovirus-specific T cells restricted by HLA-Cw* 0702 increase markedly with age and dominate the CD8+ T-cell repertoire in older people
Fiuza et al. Profile of central and effector memory T cells in the progression of chronic human chagas disease
Govender et al. T cell perturbations persist for at least 6 months following hospitalization for COVID-19
Wanjalla et al. CD4+ T cells expressing CX3CR1, GPR56, with variable CD57 are associated with cardiometabolic diseases in persons with HIV
Lu et al. Low double-negative CD3+ CD4− CD8− T cells are associated with incomplete restoration of CD4+ T cells and higher immune activation in HIV-1 immunological non-responders
Khuzwayo et al. MR1-restricted MAIT cells from the human lung mucosal surface have distinct phenotypic, functional, and transcriptomic features that are preserved in HIV infection
Conway et al. SARS-CoV-2-specific T cell responses are stronger in children with multisystem inflammatory syndrome compared to children with uncomplicated SARS-CoV-2 infection
Jost et al. Antigen-specific memory NK cell responses against HIV and influenza use the NKG2/HLA-E axis
Permar et al. Increased thymic output during acute measles virus infection
Malhotra et al. Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection
De Pablo-Bernal et al. Phenotype and polyfunctional deregulation involving interleukin 6 (IL-6)–and IL-10–producing monocytes in HIV-infected patients receiving combination antiretroviral therapy differ from those in healthy older individuals